The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
roche | 1818 |
roche palo alto | 357 |
helsinn healthcare | 54 |
pharmasset | 28 |
roche glycart | 18 |
maxygen | 5 |
riboscience | 5 |
intermune | 5 |
gilead pharmasset | 4 |
memory pharmaceuticals corporation | 3 |
roche | 322 |
roche palo alto | 79 |
helsinn healthcare | 6 |
maxygen | 5 |
neurogen corporation | 2 |
astex therapeutics | 1 |
f. hoffmann-la roche agastrazeneca | 1 |
syntex | 1 |
cv therapeutics | 1 |
pharmasset | 1 |
roche | 25 |
roche palo alto | 8 |
helsinn healthcare | 2 |
riboscience | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
pyrrolopyrazine kinase inhibitors | 79 | 2008 |
isoxazolo-pyridine derivatives | 59 | 2007 |
liquid pharmaceutical formulations of palonosetron | 49 | 2003 |
methods for improving pharmacokinetics | 40 | 2009 |
novel pyridinones and pyridazinones | 39 | 2008 |
novel substituted pyridin-2-ones and pyridazin-3-ones | 39 | 2008 |
heteroaryl pyrrolidinyl and piperidinyl ketone derivatives | 37 | 2006 |
heterocyclic antiviral compounds | 35 | 2009 |
diaminopyrimidines as p2x3 and p2x2/3 antagonists | 35 | 2004 |
tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinerg… 🛈 | 31 | 2007 |